SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 15,592.80 |
| Enterprise Value ($M) | 24,895.59 |
| Book Value ($M) | 9,525.37 |
| Book Value / Share | 21.49 |
| Price / Book | 1.64 |
| NCAV ($M) | -4,733.19 |
| NCAV / Share | -10.68 |
| Price / NCAV | -3.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.00 |
| Return on Assets (ROA) | 0.00 |
| Return on Equity (ROE) | 0.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.19 |
| Current Ratio | 2.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,554.91 |
| Assets | 16,813.47 |
| Liabilities | 7,288.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,237.00 |
| Operating Income | 923.00 |
| Net Income | 43.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 2,144.00 |
| Cash from Investing | -1,029.00 |
| Cash from Financing | -945.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | General Atlantic Llc | 5.60 | 0.00 | |
| 13G/A | Morgan Stanley | 9.90 | -21.85 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 1.59 | -71.82 | |
| 13G/A | Fmr Llc | 10.00 | 99.78 | |
| 13G/A | Vanguard Group Inc | 8.08 | 20.22 | |
| 13D/A | Giuliani Mario Germano | 10.00 | -5.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 204,246 | 1,378,976 | 14.81 | |
| 297,065 | 1,912,847 | 15.53 | |
| 428,396 | 2,389,440 | 17.93 | |
| 254,779 | 2,233,628 | 11.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNXT – RenovoRx, Inc. | ROIV – Roivant Sciences Ltd |
| RPHM – Reneo Pharmaceuticals, Inc. | RPTX – Repare Therapeutics Inc |
| RTVA – Artiva Biotherapeutics Inc |
Financial data and stock pages provided by
Fintel.io